SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,998 | -53.9% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $13,000 | -26.1% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $17,600 | -43.9% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $31,400 | -35.9% | 10,000 | 0.0% | 0.01% | -40.0% |
| Q3 2022 | $49,000 | +19.5% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $41,000 | -29.3% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $58,000 | -22.7% | 10,000 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $75,000 | -16.7% | 10,000 | 0.0% | 0.02% | -25.0% |
| Q3 2021 | $90,000 | -25.0% | 10,000 | -0.5% | 0.02% | -25.9% |
| Q2 2021 | $120,000 | -4.0% | 10,050 | +0.5% | 0.03% | -12.9% |
| Q1 2021 | $125,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |